Ranjiv Mathews, MD, FAAP

• Associate Professor of Pediatric Urology,
• The Johns Hopkins School of Medicine,
• Baltimore, Maryland

Alternatives include fecal elastase or chymotrypsin quercetin and blood pressure medication cheap atenolol 50 mg mastercard, the pancreolauryl test pre hypertension nursing diagnosis atenolol 100 mg purchase line, the bentiromide test heart attack music video 50 mg atenolol buy with amex, and breath tests with labeled triglycerides blood pressure medication that does not cause joint pain order cheapest atenolol and atenolol. With mild to moderate loss of exocrine function blood pressure medication that starts with m discount 100 mg atenolol visa, the tests all have poor sensitivity. Fecal elastase levels are normal by age 3 days in full-term newborns and by 14 days of age in preterm infants. Once a routine part of the evaluation for suspected malabsorption, the 72-hour fecal fat collection has fallen out of favor, despite being the best test for steatorrhea. The test is not specific for pancreatic disease, since diseases of the intestinal mucosa can produce steatorrhea. Families do not like to collect and store the stool and may not keep the required food diet accurately. Performance of the test in a metabolic laboratory can overcome some of these issues, but this is impractical for clinical practice. As with other noninvasive tests, the 72-hour fecal fat collection is only abnormal in the face of advanced disease. Genetic Testing the discovery of gene mutations that associate with chronic pancreatitis advanced our understanding of this disease more than any other finding before or since. During the early phases when discrete episodes of acute pancreatitis recur, the management is identical to that for acute pancreatitis. As the disease advances, therapy is directly mostly toward complications that arise such as chronic pain, pancreatic insufficiency, or diabetes mellitus. Pain Relief Persistent, unrelenting pain dominates the clinical symptoms in many patients. Furthermore, therapeutic trials of pain management have not been done in both adults and children. Typically, analgesia starts slowly with acetaminophen but usually advances quickly to narcotics. Patient comfort must take precedence over concerns for addiction, although it is important to recognize that narcotic bowel syndrome can occur with continued or escalating dosages of narcotics. A handful of trials have attempted to determine if enzyme supplementation affects chronic pain. Only two reported efficacy, and they both employed non­ enteric-coated enzymes, whereas the other studies used enteric-coated preparations. Some have interpreted the studies to suggest that enzyme supplementation is most effective in patients with some pancreatic function and predominantly small duct disease. A proton pump inhibitor should be prescribed also if non­enteric-coated enzymes are given. Based on the belief that oxidation plays a role in the pathophysiology of pancreatitis, providers have prescribed antioxidant therapy to patients with chronic pancreatitis. A recent report of adults randomized to placebo or antioxidant therapy (selenium, ascorbic acid, -carotene, -tocopherol, and methionine) reported improved pain relief in the treatment group. Still, a therapeutic trial is often done as empiric therapy for persistent pain in chronic pancreatitis. Nerve blocks and neurolysis have been more effective in patients with pancreatic cancer than in those with chronic pancreatitis. Although frequently done, endoscopic sphincterotomy with stent placement is not supported by evidence of efficacy. If the main duct is dilated, operations aimed at drainage or decompression of the duct are done. Patients with more severe, localized disease may benefit from partial pancreatic resection. After the procedure, many patients have pain relief and some have no insulin requirement. Pancreatic Insufficiency the treatment of pancreatic insufficiency currently depends on the use of pancreatic replacement therapy with extracts of porcine pancreas. There are no studies of dose range in pediatric patients with chronic pancreatitis, and doses are based on the current recommendations for treating patients with cystic fibrosis. In children or young adults with cystic fibrosis, pancreatic enzymes are given by units of lipase/kg per meal or in units of lipase/gram of fat ingested. This translates into approximately 500 to 2000 units of lipase/kg per meal, or 500 to 4000 units of lipase/gram of fat. Doses exceeding 10,000 units/kg per day are not recommended and doses in excess of 6000 units/kg per meal have been associated with colonic strictures in children younger than 12 years. Some contend that the enzymes should be given before, during, and after the meal, whereas others aver that before and during, or during and after the meal is sufficient. A recent trial found that administration of enzymes was most effective when given during or after the meal. The changing incidence of acute pancreatitis in children: a single-institution perspective. Quality of life improves for pediatric patients after total pancreatectomy and islet autotransplant for chronic pancreatitis. Infiltration of the pancreas with circulating inflammatory cells contributes to the injury seen in acute pancreatitis. The release of pancreatic enzymes into the serum produces the systemic complications of acute pancreatitis. Acinar cells release cytokines and chemokines that attract inflammatory cells into the pancreas. Vascular endothelial cells are activated to facilitate the recruitment and passage of inflammatory cells into the pancreas. A 14-month-old infant presents to the emergency department with complaints of irritability and abdominal distension. Answers "A", "C," and "D" have all been associated with an increased risk of recurrent and chronic pancreatitis. Answers "A" through "D" are all tests that might be performed to evaluate someone with acute pancreatitis, but none is sufficiently sensitive to reliably identify most patients with acute pancreatitis. Serum amylase and lipase is the most-widely utilized test to screen for acute pancreatitis. Patients can have chronic pancreatitis without ever having a demonstrated elevation of amylase or lipase. Answer "B" is incorrect because a pseudocyst can be a complication of acute pancreatitis, even though pseudocysts can be present in patients with chronic pancreatitis as well. Answer "D" is incorrect because patients can have pancreatic insufficiency without ever having pancreatitis. Answer "E" is incorrect because patients with chronic pancreatitis can present with recurrent episodes of acute pancreatitis, but not all such patients have chronic pancreatitis. To diagnose chronic pancreatitis, there must be evidence of irreversible histologic or morphologic change in the pancreas (answer "C"). Elevation of serum amylase or lipase greater than three times the upper reference limit B. The first episode occurred 8 months earlier and evaluation included normal serum calcium and serum triglyceride levels. Which of the following treatments for persistent pain in chronic pancreatitis is unequivocally supported by clinical trials Pancreatic enzyme therapy Antioxidant therapy Low-fat diet Octreotide to reduce pancreatic secretions None of the above 1026. An upper gastrointestinal series (answer "E") can identify congenital anomalies of the gastrointestinal tract that might cause obstruction of pancreatic or biliary secretions. Answer "C" is incorrect because current evidence shows that patients should be fed shortly after admission, generally after 24 hours. This practice does not appear to cause more complications and may speed recovery and improve outcome. Although answers "A" through "D" are all employed at times in an attempt to treat the pain associated with chronic pancreatitis and may appear useful in some patients, none are unequivocally supported by evidence. The use of pancreatic enzyme therapy and antioxidant therapy (answers "A" and "B") is addressed by multiple studies that have important methodologic flaws and that do not all come to the same conclusion. The use of octreotide, in an attempt to reduce pancreatic secretions (Answer "D") has only negative studies. It is clear that the systemic complications associated with acute pancreatitis are a result of the systemic immune response just as seen in other serious illnesses. The data to support the other answers are stronger and they are included in most, if not all, modern theories of the pathophysiology of acute pancreatitis. Increasing incidence of acute pancreatitis at an American pediatric tertiary care center: is greater awareness among physicians responsible Frank Brooks memorial Lecture: the early intraacinar cell events which occur during acute pancreatitis. Environmental and genetic stressors and the unfolded protein response in exocrine pancreatic function-a hypothesis. Co-localization hypothesis: a mechanism for the intrapancreatic activation of digestive enzymes during the early phases of acute pancreatitis. Involvement of autophagy in trypsinogen activation within the pancreatic acinar cells. Secretagogues differentially activate endoplasmic reticulum stress responses in pancreatic acinar cells. Early activation of endoplasmic reticulum stress is associated with arginine-induced acute pancreatitis. Hereditary pancreatitis caused by mutation-induced misfolding of human cationic trypsinogen: a novel disease mechanism. Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity. Pancreas divisum is not a cause of pancreatitis by itself but acts as a partner of genetic mutations. Influence of contrast-enhanced computed tomography on course and outcome in patients with acute pancreatitis. Magnetic resonance cholangiopancreatography in the preoperative assessment of patients with biliary pancreatitis. Diagnostic criteria in predicting a biliary origin of acute pancreatitis in the era of endoscopic ultrasound: multicentre prospective evaluation of 213 patients. The prevalence and characteristics of genetic pancreatitis in children with chronic and recurrent acute pancreatitis. Accuracy of magnetic resonance cholangiopancreatography in the diagnosis of pancreas divisum. Towards the ideal quantitative pancreatic function test: analysis of test variables that influence validity. Magnetic resonance cholangiopancreatography of biliary system abnormalities in children. Highly resolved freebreathing magnetic resonance cholangiopancreatography in the diagnostic workup of pancreaticobiliary diseases in infants and young children-initial experiences. Does endoscopic ultrasound have anything to offer in the diagnosis of idiopathic acute pancreatitis Narcotic analgesic effects on the sphincter of Oddi: a review of the data and therapeutic implications in treating pancreatitis. Immediate oral feeding in patients with mild acute pancreatitis is safe and may accelerate recovery-a randomized clinical study. A prospective, randomized trial of clear liquids versus low-fat solid diet as the initial meal in mild acute pancreatitis. Meta-analysis of parenteral nutrition versus enteral nutrition in patients with acute pancreatitis. Pancreatic pseudocyst in children: the impact of management strategies on outcome. A randomized controlled trial of antioxidant supplementation for pain relief in patients with chronic pancreatitis. The role of total pancreatectomy and islet autotransplantation for chronic pancreatitis. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three-way crossover study. Chapter 83 Total Pancreatectomy with Islet Autotransplantation and Pancreatic Allotransplantation R. Although an uncommon disease in childhood and adolescence, with an incidence of 4 to 13 cases per 100,000, the incidence of chronic pancreatitis in children is comparable to that seen in adults. The clinical presentation and course of chronic pancreatitis are similar to that seen in adults. Thus, the presentation in younger years is also one of abdominal pain, and definitive management focuses on elimination of pain to improve quality of life. There is a particular form of idiopathic chronic pancreatitis, termed tropical pancreatitis, which can present as recurrent abdominal pain in adolescence and occurs in endemic regions. The etiology of pancreatitis is of particular interest when considering the differences between adult and pediatric patients. In adults, the principal causes are alcohol use and biliary tract disease, whereas in children hereditary and idiopathic causes predominate, especially in patients who require surgery. The conflicting outcome variables of possible interest would include eventual relief of pain as a consequence of so-called "burn-out" versus the risk of developing narcotic dependence and the development of irreversible exocrine and endocrine insufficiency during the period of medical management. These competing outcomes are expected to likely play out over the course of a longer life expectancy in children than in the adult population. The natural history data for chronic pancreatitis in adults are illustrative for their shortcomings. The results from some European centers that have tried to investigate the long-term success of complete pain relief with medical management alone have not been confirmed elsewhere. Data from these centers suggest that any sustained pain relief for chronic pancreatitis requires decades to achieve, requires removal of the initiators of pancreatitis (alcohol in adults), is likely dependent on the type of pancreatic pain experienced (type A vs type B), and will occur predominantly at only the expense of addiction and complete functional insufficiency. In adults, the major causes of chronic pancreatitis are potentially mutable, especially the elimination of alcohol. In the pediatric population, the most common causes of chronic pancreatitis cannot be altered because they include idiopathic and hereditary etiologies.

A vast network of extrahepatic lymphatics mostly localized to capsule prehypertension heart attack cheap 50 mg atenolol free shipping, also exits hypertension medication guidelines atenolol 50 mg order with amex. Chapter 67 - Developmental Anatomy and Physiology of the Liver and Bile Ducts 817 Its function becomes evident only when there is increased resistance to intrahepatic blood flow in diseased states blood pressure young adults atenolol 100 mg mastercard, at which time lymphatics hypertrophy to absorb the resultant transudate blood pressure chart during pregnancy buy atenolol 50 mg without a prescription, clinically seen as ascites heart attack young woman cheap 100 mg atenolol fast delivery. Umbilical vein Sinus venosus A Vitelline vein Diaphragm Gut Ductus venosus the hepatic lobule is a carefully orchestrated unit comprising radially arranged hepatocyte cords lined by fenestrated sinusoids. It is the product of the close interactions between vascular precursors, hepatoblasts, and mesenchyme during the early phases of development. It relies on two substrate supply routes, the hepatic artery and the portal vein, and two metabolite exit routes, the hepatic veins and the biliary system. Anatomic specialization of hepatocyte function occurs postnatally through a mechanism leading to "enzymatic zoning" (zones 1, 2, and 3) from the portal triad to the central vein: hepatocytes express different enzymes according to their position along the portal to central axis. First, there is a sinusoidal concentration gradient from portal triad to central vein pertaining to oxygen saturation as well as to the concentration of any nutrient or xenobiotic transported through the portal vein. Second, there exists a cytosolic concentration gradient of both solutes and enzymes across the hepatocyte, as bile acids (and other biliary constituents) are synthesized and transported across the hepatocyte to the apical membrane to be exported via the canaliculus. Finally, there is a concentration gradient within the biliary tree, as both the composition and the concentration of bile change as it travels through the canaliculi and interlobular bile ducts toward the hilum of the liver. Until recently, the molecular mechanisms controlling liver zonation were poorly understood. Frontal section through a developing human embryo at 6 weeks (A) and 10 weeks (B): venous system. They have not fused on the midline yet, and are not connected to the umbilical vein. The newly formed portal vein returns blood from the mesenteric tree to the liver (low oxygenation saturation). Schematic representation of the three different functional and concentric zones of the liver lobule and the putative contribution of the Wnt pathway in its zonal organization. The dark green zone is periportal, whereas the dark gray is centrolobular or pericentral. A central to portal gradient of Wnt ligands contributes to differential metabolic and structural gene expression, while Wnt antagonists likely are expressed in a reverse gradient offering a second level of gene expression control from the periportal area toward the center of the lobule. For example, the requirements of liver regeneration (-catenin­dependent oval cell proliferation) are not compatible with the expression of ammoniametabolizing enzymes. This may in part explain the hyperammonemia in acute liver failure and other situations of insufficient hepatic cell mass. As described earlier, liver anatomy is defined by vascular and biliary development. The result is an organ composed of eight surgically divisible segments defined by vascular and biliary conduits. In partial hepatectomies or segmental liver transplantations, dissection is performed according to this segmental anatomy. Furthermore, the placenta and maternal liver perform many of the necessary functions in lieu of the fetal liver until birth. One might hypothesize that the hepatic-enriched molecular network is at the root of this variability. This is the surgical anatomy used both in partial hepatectomy and in reduced-graft and living-related liver transplantation. The purpose of both the anatomic and physiologic development of the liver is to prepare the fetus for the drastic transition of parturition and extrauterine life. Lipids During the first few days of life, an additional metabolic pathway matures to meet the metabolic demands of the fetus: fatty acid oxidation and ketogenesis. Fatty acid oxidation allows the utilization of fats in breast milk transported to the liver by the portal system. Ketogenesis offers a substrate for cerebral metabolism and hepatic gluconeogenesis. Instead, it needs to rely on stores and the ability to synthesize glucose de novo. Thus, the fetal liver accrues a large amount of glycogen during the second half of gestation, which in turn it consumes postnatally. Similarly, the enzymatic pathways for gluconeogenesis reach functional levels by term. Consequently, premature infants are at risk for hypoglycemia for two reasons: insufficient glycogen accrual and immature gluconeogenesis enzymes. As discussed earlier, an emerging theme in the understanding of liver development is the temporal regulation of genes. In other words, genes that are "used" for one purpose in very early liver development can be reactivated later in development for another mission. Such is the case of Foxa3, which participates in early cell-fate decisions in pancreas and liver specification. In adult Foxa3 -/- mice, fasting blood glucose is significantly lower than in fasted wild-type mice. The synthesis of this particular subset of vital circulating proteins has reached maturity by parturition. Although the enzymatic pathways of the coagulation cascade are mature at birth, newborns are at risk for a bleeding diathesis, because their gut is not yet colonized with vitamin K­producing bacteria; hence the universal recommendation for neonatal vitamin K administration. Hormones the liver also serves an endocrine function via the tight regulation of the half-lives of hormones such as insulin and the sex hormone estrogen. The liver responds to insulin by storing carbohydrates as glycogen and to glucagon, by initiating gluconeogenesis. First, at the onset of bile acid synthesis, rather than the functional adult-type bile acids, the developing hepatocyte produces "atypical" bile acids, which may act as trophic factors for the developing biliary tree. Second, overall synthesis in the fetus is less abundant than that in the mature infant. Third, enteral and hepatic uptake of secreted and circulating bile acids is immature, and thus less efficient than in the adult. Finally, the ability of the hepatocyte to excrete bile acids into the canaliculus does not mature until well into the first year of life. On a molecular level, a significant finding since the last edition has been the identification of the important role of the transcription factor FoxA2 in bile acid homeostasis. Developmental genes are reactivated in the adult liver to serve homeostatic functions, among others. Toward term, transcription and translation of albumin begins, although serum levels do not yet reach adult levels. During the first few months of life, -fetoprotein levels drop under the control of transcriptional repressors,76-78 as albumin levels rise. All of the other major secreted proteins are synthesized at the time of birth: coagulation factors, complement proteins, and apolipoproteins. The infant has about 60% of the circulating concentration of albumin of a 1-year-old child (2. The clinical corollary is that this affects serum levels of unconjugated bilirubin in the neonate and of xenobiotics in the infant. Concurrently, intracellular enzyme concentrations and functions mature as the hepatocyte prepares for detoxification and conjugation. Cholesterol and Phospholipids Bile acid metabolism is inexorably linked to cholesterol and phospholipid metabolism in humans. Therefore, stem cells are the most attractive source of future therapeutic liver and pancreas cells, hence the need to understand liver and pancreas development in vivo before making functional tissue in vitro. The purpose of discussing stem cells in this section is twofold: to understand their role in regeneration and to gain an understanding of experimental efforts to direct stem cells toward a hepatic fate in vitro. Through its vast array of transferases and conjugation reactions, the liver, together with the kidney, is the main factor protecting the organism against harmful xenobiotics, such as medications, toxins, and bacteria derived from the gut via the portal circulation. Hepatectomy models in mice have shown that liver volume, although not structure, is restored after 2 weeks. Liver regeneration is a heterogeneous process,85 which involves the recruitment of many different cells: hepatocytes, hepatocyte progenitors (or stem cells), endothelial cells, leukocytes, and stellate cells. In the mouse, the sequence of events begins by hepatocyte replication at 24 hours postinjury, followed by biliary epithelial cells and endothelial cells within 72 hours. Liver regeneration is multifactorial, and this section focuses on the cell types and molecules currently under the most scientific scrutiny. The term stem cell is used to describe cells involved in both tissue homeostasis and repair after damage. These somatic progenitor cells have two main characteristics: self-maintenance and multipotency. They are conditional stem cells and the alleged progeny of organ-specific stem cells. Oval cells can differentiate into hepatocytes, cholangiocytes, and abnormal ductular reactive cells. The population of hematopoietic cells decreases rapidly in the first 2 months of life. To this end, the liver macrophages (Kupffer cells) are localized along the sinusoids, and display specialized functions according to their position along the portal-to-central axis. Likewise, other cells of the innate and adaptive immune systems are dispersed throughout the liver, consistent with the form-andfunction paradigm. The balance of this unique immune makeup likely explains the tolerogenic potential of the liver as well as its critical role in the systemic inflammatory cascade observed in situations of liver failure. The clinical ramifications of the immune role of the liver are only beginning to be understood. Recently, the Notch/ Jagged pathway was shown to confer regenerative potential to dividing hepatocytes in a mouse model of liver regeneration. Future studies in the field of liver regeneration and stem cell biology should aim to identify the crossregulation between these different pathways. A large body of literature86-88 provides compelling evidence suggesting that hematopoietic precursors and hepatic precursors share cell surface markers, and thus probably a common lineage. Furthermore, it appears that certain cells derived from the bone marrow have the ability to migrate to the liver, and may therefore also be an important source of hepatocyte precursors. In summary, the liver has three in situ compartments of alleged stem cells: the hepatocytes themselves, the periportal oval cells, and the periductular organ specific stem cells. Current data suggest that each of these cells responds to different permissive conditions (different disease or injury) to acquire a hepatocyte or biliary phenotype, and that developmental pathways are reactivated in this process. In addition, the liver, like many other organs, has a circulating pool of stem cells derived from the bone marrow. As research in the field of stem cells progresses, clinicians undoubtedly will see this knowledge applied to the management of acute and chronic liver diseases. The identification of two molecules with an endoderminducing potential is an exciting advance in the field. In particular, an appreciation for the molecular regulation of liver development highlights the research efforts of many who are aiming to generate endodermal organs "in a dish": for example, hepatocytes or pancreatic islet cells for the purposes of cell transplantation. Oval cells, which lie adjacent to the canals of Hering, can generate both mature cell types. Other liver-specific stem cells thought to reside close to the portal triad, also participate in liver regeneration. Review article: a medicine based on cell transplantation-is there a future for treating liver diseases Intrahepatic bile ducts develop according to a new mode of tubulogenesis regulated Chapter 67 - Developmental Anatomy and Physiology of the Liver and Bile Ducts 822. Ductal plate formation and remodeling start at the hilum and continue toward the periphery postnatally, much like the portal vein during development. In premature infants in whom enteral feedings are held after birth, the ductus venosus may be slow to close, resulting in blood shunting from the left portal vein to the ductus venosus and bypassing the liver. In some cases, the ductus venosus never closes, leading to persistent encephalopathy in childhood as blood from the gut shunts to the systemic circulation without being properly detoxified by hepatocytes. The placenta and maternal liver perform many of the necessary functions of the fetal liver until birth, when the loss of umbilical blood at birth acts as an inducer for many enzymes. Anatomic specialization of hepatocyte function then begins postnatally, leading to "enzymatic zoning," a process where hepatocytes express different enzymes according to their position along the portal-to-central axis. Completion of zonation, which results in a fully mature hepatic metabolism, is not reached until the end of the first year of life. An otherwise healthy child presents with transient mental status changes and high ammonia levels. During the first few months of life, -fetoprotein levels decrease under the control of transcriptional repressors, as albumin levels rise. Sfrp5 coordinates foregut specification and morphogenesis by antagonizing both canonical and noncanonical Wnt11 signaling. A bipotential precursor population for pancreas and liver within the embryonic endoderm. Different thresholds of fibroblast growth factors pattern the ventral foregut into liver and lung. Mypt1-mediated spatial positioning of Bmp2-producing cells is essential for liver organogenesis. Distinct populations of endoderm cells converge to generate the embryonic liver bud and ventral foregut tissues. Hex homeobox gene controls the transition of the endoderm to a pseudostratified, cell emergent epithelium for liver bud development. The homeobox gene Hex is required in definitive endodermal tissues for normal forebrain, liver and thyroid formation. Homeobox gene Hex is essential for onset of mouse embryonic liver development and differentiation of the monocyte lineage.

Discount atenolol 100 mg with mastercard. How to Use Wrist Blood Pressure Monitor.

Ideally blood pressure chart high and low proven atenolol 100 mg, a combination of the measures listed earlier will provide the most thorough approach to a complete nutri tional assessment blood pressure chart for tracking cheap 100 mg atenolol amex. This infor mation considered in conjunction with a physical assess ment directs the care of the patient arrhythmia questionnaire cheap 50 mg atenolol free shipping. A nutritionfocused physical examination must evaluate the patient from head to toe heart attack while running purchase atenolol american express. An overall review of height and weight; assessment of muscle and fat mass; the appearance of skin blood pressure normal range for adults order atenolol master card, hair, eyes, and fingernails; as well as the presence or absence of edema should be included. Signs of bone disease, such as rachitic rosary and bowed legs, may be observed during the examination. Although many physical find ings of the clinical assessment are most likely multi factorial, some are diagnostic of nutrient deficiencies (Table 864). As part of the physical assessment, recognizing the loss of subcutaneous fat is of utmost importance. Overall, muscle wasting should be identified in areas that lose bulk and tone due to malnutrition; areas of focus should include the clavicle, shoulder, temple, and calf. It is important to note that the lower body is less sensitive to change in weight than the upper body, and acute weight loss can be reflective of hydration status or a result of a viral/intercurrent illness. In these cases, assessment of weight change and edema together will help the clinician identify loss of lean body mass that is masked by fluid retention. The visual impres sions of body composition can be corroborated with objective anthropometric measurements. Weight: Suboptimal weight gain or weight loss is an indicator of acute undernutrition, and in the pediatric population, body weight loss in the face of poor dietary intake can occur in less than one week. In malnourished children, a drop in percentile curves appears first in weight, then in height, and finally in head circumference measures. Weights should be obtained consistently with minimal clothing and without shoes; infants should be weighed in a dry diaper or naked, if possible. In children younger than 2 years of age, length should be obtained using a length board, with the patient lying in the recumbent position. Children older than 2 years of age are measured without shoes using a stadiometer. The child should stand erect with heels, shoulders, and but tocks all touching the measurement on the wall. Height and weight measurements can be converted to Zscores, which are values that represent standard devia tions from the median height and weight values for a specific age. The best appli cation of skinfold calipers is to determine if subcutaneous fat is increasing or decreasing, but not for predicting total body fat. The error for skinfold measuring has been reported to be 3% to 5% in agespecific populations. This is based on evidence that starved or malnourished humans use stored energy in the form of fat and skeletal muscle. Skinfold measurements cannot be taken in infants <3 months old secondary to fluctuation in fluid compartments. It is imperative that the person obtaining the measurement be well trained and familiar with the process. In addition, it is just as important to gain an understanding of the household structure surrounding Chapter 86 - Nutritional Assessment 1075 family meal times. Diet history should not only include table foods, but also drinks/beverages such as milk, water, soda, and fruit juice. Information on daily vitamin and mineral supplements, as well as possible herbal supplements should be included. In an outpatient setting, obtaining a 24hour diet recall can be useful in gaining a general sense of the types of food(s) consumed by the child; however, this can be misleading, as the information provided reveals the diet for only one day. This approach can be modified by asking the family/child "What does a typical day look like for breakfast, lunch, dinner, and snacks. A more valid tool that is widely used in clinical prac tice to assess diet adequacy is the 3day food record. Special attention should be paid to the quantity of dietary fat infants and toddlers consume, because fat is a concentrated source of energy, and plays a critical role in brain growth and central nervous system function. Parents who may be restricting dietary fat for perceived health reasons need to be counseled on the biologic need of fats in the first 2 to 3 years of life. Education should be provided to reassure families that in the 6 to 24 month period, the amount of fat intake does not show associa tions with adult disease related to excessive intake of dietary fat. The area of the gastrointestinal tract that is affected by disease may further serve as a guide in selecting appropriate labo ratory assessment tools. A general laboratory assess ment should include review of electrolytes, complete blood count, complete metabolic panel with serum ami notransferases, serum proteins, and prothrombin time. Specific vitamin and mineral labs may be assessed based on clinical findings and underlying diagnoses. Although inex pensive and readily available, it can be less than ideal as a marker of nutritional adequacy for a variety of reasons. The halflife of albumin is 18 to 20 days, which may cause a delay in diagnosing nutritional depletion or extend the time in recognizing nutritional repletion. Albumin levels may be decreased with infection, trauma, liver disease, enteropathies, renal disease, and overhydration. Transferrin, retinolbinding protein, and thyroxin binding prealbumin are serum proteins that may be useful in acutely assessing response to nutritional therapy. In contrast to serum albumin, thyroxinbinding prealbu min has a short halflife of 1 to 2 days, which can be helpful to trend when repleting an undernourished patient. Values may be low in acute illness, with prefer ential synthesis of acutephase proteins and fluid shifts. Some nutrients of specific concern include but are not limited to iron, calcium, vitamin D, and zinc. In children, stored iron is totally depleted when serum ferritin is below 12 µg/L. Calcium absorption is negatively impacted by magnesium deficiency and use of glucocorticoids. Calcium losses are likely increased with diarrhea and malabsorption in many gastrointestinal dis eases. Serum calcium concentration is regulated by a complex interaction with parathyroid hormone, serum phosphate, and vitamin D. Ionized calcium is more useful in clinical assessment than serum calcium, as it is free flowing in the bloodstream and not bound to proteins. When supplementing calcium, a maximum of 500 mg is recommended at one time to maximize the efficiency of absorption. For example, children who are malnourished due to starvation alone, as in the case of poverty or social neglect, are often responsive to appro priate nutritional interventions. The presence of malnutrition in these chil dren may also compromise the clinical response to medical therapy. Zinc deficiency should be consid ered with increased losses and/or decreased absorption such as in acrodermatitis enteropathica. A diet history of low meat intake or high intake of legumes and grains with phytates that bind zinc, thereby inhibiting its absorption, are risk factors for zinc deficiency. Zinc level will vary with albumin level, as 50% of serum zinc is bound to albumin. Serum zinc levels vary with the time of day that the sample was collected in studies in healthy individu als. Nonetheless, plasma zinc concentration, even with its limitations, is the best indicator of total body zinc status. The active metabolite form of vitamin D, 1,25dihydroxyvitamin D, promotes intestinal absorp tion of calcium and phosphorus and maintains serum homeostasis. Use of longterm glucocorticoid steroids appears to cause some degree of vitamin D resistance. The clini cian must identify problems associated with reduced nutritional intake, energy/nutrient malabsorption, or increased expenditure of energy, acting independently or in concert with one another13 Various methods can be used to estimate the nutri tional needs of children (Tables 865 and 866). Although much is known about the nutritional requirements in certain chronic illnesses, validated guidelines are often lacking or incomplete for the management of secondary under nutrition in many of these illnesses. Poor contractility and diminished cardiac output can result from atrophy of the myocardium. Although fatty infiltration of the liver is common, syn thetic function usually is preserved. Insulin secretion decreases and basal metabolic rate decreases by 20% to 25% to conserve energy. Refeeding syndrome occurs when the body shifts from protein and fat catabo lism to an anabolic state, where glucose becomes the primary source of energy. This leads to the intracellular uptake of glucose, potassium, magnesium, and phosphate, resulting in hypokalemia, hypomagnese mia, and hypophosphatemia. Insulin also exhibits a natri uretic effect on the kidneys, causing sodium and fluid retention and expansion of extracellular fluid volume. Rapid correction of undernutrition may cause fluid shifts and intravascular volume overload, putting the under nourished patient with myocardial atrophy at risk for congestive heart failure. This includes patients with histories of anorexia nervosa, chronic malnutrition (from condi tions such as chronic liver disease or congenital heart disease), malabsorptive syndromes (including inflamma tory bowel disease, cystic fibrosis, chronic pancreatitis, and short bowel syndrome), cerebral palsy and other con ditions causing dysphagia, and children of neglect. Furthermore, once a repletion plan is implemented, adjustments must be made based on objective measurements such as weight gain and laboratory data. During this time, the focus is on stabilization and correction of metabolic imbalances, addressing medical emergencies such as severe anemia and shock, and treatment of infec tion and other underlying disorders. The goal of this phase is to prevent recurrence and ensure continued stability of nutritional status. One suggested criterion is that the child must be able to maintain weight for height above the 10th percentile and a normal rate of weight gain for age on at least two assessments, 1 month apart, on a normal diet for age. Furthermore, it is important to note that children with gastrointestinal diseases should always be consid ered high risk, irrespective of whether they initially present with malnutrition. Those who have a history of malnutrition in addition to their disease would need to be monitored particularly closely for the duration of their care. The intricate relationship between digestive function, nutritional status, and health must be considered during every initial patient evaluation and throughout followup care. Maintenance of ageappropriate growth despite gas trointestinal illness should be a goal for every patient. Defining pediatric mal nutrition: a paradigm shift toward etiologyrelated definitions. Pediatric nutrition in chronic disease and developmental disorders: prevention, assessment and treatment. Inflammation as the key interface of the medical and nutrition universes: a provocative examination of the future of clinical nutrition and medicine. Iron deficiency is the most common nutritional deficiency in the United States, affecting mainly older infants, young children, and adolescent girls following onset of menarche. For most patients with gastrointestinal disorders, a comprehensive assessment should include all of the above components, as assessment by diet history alone can leave the clinician with an incomplete presentation. Niacin deficiency results in the clinical syndrome known as pellagra, meaning "rough skin. Anthropometric growth measurements, biochemical analyses, and physical assessment B. Detailed diet history, visual assessment of edema, muscle and fat measurements, and oral health assessment C. Indirect calorimetry biochemical analyses, inflammation status assessment, and anthropometric growth measurements D. Clinical history with physical assessment, detailed diet history, anthropometric growth measurements, and biochemical analyses 3. Which vitamin can be synthesized from tryptophan, and is associated with severe deficiency symptoms including diarrhea, dermatitis, dementia, and death Prevalence and risk factors for hypovitaminosis D in young patients with inflam matory bowel disease. Biomarkers of nutrient bioactivity and efficacy: a route toward personalized nutrition. New norms of upper limb fat and muscle areas for assessment of nutritional status. The presentation and use of height and weight data for comparing the nutritional status of groups of children under the age of 10 years. There is a multitude of tubes available to allow access to the gastrointestinal tract. These tubes vary by composition, inner and outer diameters, presence or absence of weighted tip, tip size and shape, and location and number of access ports and egress ports. There are tubes intended to remove content or decompress the gastrointestinal tract, as well as to introduce content, usually nutrients or medications, into the gastrointestinal tract. For example, nasogastric, or nasoenteric tubes are placed through the nose into the stomach or small bowel. In some situations, the tube may be placed through the mouth and passed into the stomach or small bowel. Natural orifice tubes are generally easy to place but frequently become clogged or dislodged. If the tube is to be used over the long term, surgical placement is considered (gastrostomy, jejunostomy, or gastrojejunostomy). These tubes are placed through the skin into the gastrointestinal tract (percutaneous).

It is accurate in finding the exact pathology and at the same time provides access for therapeutic intervention (dilation and stenting) heart attack grill death atenolol 50 mg buy otc. Percutaneous balloon dilation of the stricture and stenting with internal/external drainage and follow-up dilation C heart attack 80 damage discount 100 mg atenolol amex. Viral hepatitis hypertension levels atenolol 50 mg generic, especially hepatitis A arrhythmia getting worse 50 mg atenolol order with amex, in patients not vaccinated against the virus arrhythmia joint pain purchase atenolol 50 mg mastercard, could be a possibility, although it is expected to be seen more frequently in school-age children. The most likely diagnosis is acute cellular rejection in an adolescent who is noncompliant with her care and medications. Unfortunately, this is currently the leading Chapter 78 - Liver Transplantation in Children 976. Biliary stricture is a serious condition and must be repaired, especially in a child. Permanent stenting is also not an option because of associated complications and especially in a child with a long life expectancy. It can be done repeatedly through the initial access line until the desired result is obtained. In cases of no response to this approach or recurrence of the stricture, operative intervention is indicated. Operative approach is probably the most definitive way to treat the problem but will require a relatively big operation with all the associated potential complications. Pediatric liver transplantation-a review based on 20 years of personal experience. Long-term survival and late graft loss in pediatric liver transplant recipients-a 15-year single-center experience. Predictors of outcomes after pediatric liver transplantation: an analysis of more than 800 cases performed at a single center. Transplantation of a donor liver to 2 recipients (splitting transplantation)-a new method in the future development of segmental liver transplantation. Pediatric liver transplantation: from the full-size liver graft to reduced, split, and living related liver transplantation. Optimal therapy for biliary atresia: portoenterostomy ("Kasai" procedure) versus primary transplantation. Liver transplantation for end stage liver disease associated with alpha-1-antitrypsin deficiency in children. A critical review of the healthrelated quality of life of children and adolescents after liver transplantation. Neurodevelopmental outcome of young children with extrahepatic biliary atresia 1 year after liver transplantation. Living related liver transplantation in children with hypoxemia related to intrapulmonary shunting. Liver transplantation for pulmonary vascular complications of pediatric end-stage liver disease. Early liver transplantation is crucial in children with liver disease and pulmonary artery hypertension. Parameters influencing survival in the first 318 patients reported to the fulminant hepatic failure surveillance study. Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. Analysis of serum inflammatory mediators identifies unique dynamic networks associated with death and spontaneous survival in pediatric acute liver failure. Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebocontrolled clinical trial. Treatment of unresectable hepatoblastoma with liver transplantation in the pediatric population. Liver transplantation in children with biliary atresia and vascular abnormalities. Biliary atresiapolysplenia syndrome: surgical and clinical relevance in liver transplantation. Intraoperative changes in blood coagulation and thromboelastographic monitoring in liver transplantation. Choice of surgical technique influences perioperative outcomes in liver transplantation. Initial clinical experience in 20 pediatric liver transplantation from living relatives as donors. Living-donor liver transplantation using the left liver, with special reference to vein reconstruction. Long-term outcomes of 600 living donor liver transplants for pediatric patients at a single center. Living donor liver transplantation in Japan and Kyoto University: what can we learn One hundred nine living donor liver transplantation in adults and children: a single center experience. Randomized trial of tacrolimus versus cyclosporine microemulsion in renal transplantation. Steroids, azathioprine in children undergoing liver transplantation: randomized European multicenter trial. Steroid-free, tacrolimusbasiliximab immunosuppression in pediatric liver transplantation: clinical and pharmacoeconomic study in 50 children. A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation. Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial. Mycophenolate mofetile for renal dysfunction in liver transplant recipients on cyclosporine or tacrolimus: randomized, prospective, multicenter pilot study results. Replacement of calcineurin inhibitors with mycophenolate mofetil in liver transplant recipients with renal dysfunction: a randomized controlled study. Rejection in liver allograft recipients, clinical characterization and management. Risk factors for liver rejection: evidence to suggest enhanced allograft tolerance in infancy. Predictive factors of early postoperative graft function in human liver transplantation. Primary graft dysfunction after liver transplantation: from pathogenesis to prevention. The use of percutaneous transluminal angioplasty in hepatic artery stenosis after liver transplantation. Hepatic artery stenosis and thrombosis in transplant recipients: doppler diagnosis with resistive index and systolic acceleration time. Hepatic artery angioplasty after liver transplantation: experience in 21 allografts. Selective revascularization of hepatic artery thrombosis after liver transplantation improves patient and graft survival. Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporin era. Delayed hepatic artery thrombosis in adult orthotopic liver transplantation: a 12-year experience. A comparison of whole liver, reduced-size graft, and graft from living related donor. Stenosis of the inferior vena cava after liver transplantation: treatment with Gianturco expandable metallic stent. The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Prospective study of hepatobiliary scintigraphy and endoscopic cholangiography for the detection of early biliary complications after orthotopic liver transplantation. Long-term follow-up of percutaneous transhepatic balloon cholangioplasty in the management of biliary strictures after liver transplantation. An endoscopic approach to biliary complications following orthotopic liver transplantation. Infection and associated risk factors in the immediate postoperative period of pediatric liver transplantation. Does previous abdominal surgery alter the outcome of pediatric patients subjected to orthotopic liver transplantation Early outcome of liver transplantation in patients with history of spontaneous bacterial peritonitis. Postoperative infectious complications after pediatric liver transplantation: a study of 48 transplants. Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation. Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein Barr virus disease and liver transplantation in children. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Efficacy and safety of valganciclovir in liver-transplanted children infected with Epstein-Barr virus. Chronic high Epstein-Barr viral load carriage in pediatric liver transplant recipients. Posttransplant lymphoproliferative disorder-the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus. Natural history of Epstein-Barr viral load in peripheral blood of pediatric liver transplant recipients during treatment posttransplant lymphoproliferative disorder. Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Epstein-Barr virus-related posttransplant lymphoproliferative disease in solid organ transplant recipients. The involvement of the gastroduodenal tract in posttransplant lymphoproliferative disease in pediatric liver transplantation. The management of Epstein-Barr virus associated posttransplant lymphoproliferative disorders in pediatric solid organ transplant recipients. Epstein-Barr virusinduced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. New strategies in the prevention and management of Epstein-Barr virus infection and posttransplant lymphoproliferative disease following solid organ transplantation. Low-dose chemotherapy for Epstein-Barr virus-positive posttransplant lymphoproliferative disease in children after solid organ transplantation. Universal occurrence of glomerular abnormalities in patients receiving liver transplantation. The effect of longterm calcineurin inhibitor therapy on renal function in children after liver transplantation. Orthotopic liver transplantation reverses the adverse nutritional changes of end-stage liver disease in children. Health-related quality of life in pediatric liver transplant recipients: a single-center study. Parental psychological outcomes in pediatric liver and/or intestinal transplantation: pretransplantation and early posttransplant period. Long-term nutritional and neurodevelopmental outcome of liver transplantation in infants aged less than 12 months. Non-adherence to posttransplant care: risk factors and outcomes in adolescent liver transplant recipients. Long-term outcome of pediatric liver transplantation for biliary atresia: a 10-year follow-up in a single center. Decreased mortality from technical failure improves results in pediatric liver transplantation. Liver transplantation in children with chronic end-stage liver disease: factors influencing survival after transplantation. Short- and long-term results of liver transplantation in infants aged less than 6 months. Infant pediatric liver transplantation results equal those for older pediatric patients. Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine. Rejection and steroid dependence: unique risk factors in the development of pediatric posttransplant de novo autoimmune hepatitis. Progressive histological damage in the liver allografts following pediatric liver transplantation. Combined liver-kidney transplant for the management of methylmalonic aciduria: a case report and review of the literature. The current management of hepatoblastoma: a combination of chemotherapy, conventional resection, and liver transplantation. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence. Emergency liver transplantation in neonates with acute liver failure: long-term follow-up. Clinical tolerance following liver transplantation: long-term results and future prospects. Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Improved diagnostic modalities, such as abdominal ultrasound, have led to "incidental" or "silent" gallstones being detected more often in children, even in utero.

A total of 13 liver biopsies were obtained from five patients over a mean of about 5 years showing progression of fibrosis stage in four children radial pulse blood pressure 90 generic atenolol 100 mg online. During follow-up blood pressure device order generic atenolol line, two children died and two underwent liver transplantation for decompensated cirrhosis arteria del corazon order atenolol 100 mg on-line. The most common symptoms at presentation in children are fatigue and right upper quadrant or diffuse abdominal discomfort blood pressure chart for excel atenolol 100 mg with mastercard. However heart attack 2013 film generic 50 mg atenolol amex, routine noninvasive evaluation (biochemical parameters, imaging tests, and serum biomarkers) should be used as the first step to confirm the diagnosis of fatty liver disease, especially in the typical patient with characteristic features of metabolic syndrome. Moreover, it is helpful in ruling out alternate causes resulting in hepatic steatosis, in particular chronic hepatitis C infection, Wilson disease, autoimmune hepatitis, and other metabolic liver disorders. In addition, histology permits the monitoring of disease progression and the response to therapy, because liver enzymes may decrease during the course of the disease regardless of whether fibrosis progresses or improves. Transaminases may range from normal to 4 to 6 times the upper limit of normal, but mild elevations are usually seen ranging between 1. Insulin resistance can be determined by fasting insulin levels or by further studies if necessary (glucose challenge or glucose tolerance test). Albumin, bilirubin, and platelet levels are usually normal, unless the disease has evolved to cirrhosis. A liver biopsy is still considered the gold standard; however, this invasive procedure is not suitable for screening and risk stratification of children with this condition. There is a great need to develop noninvasive, simple, and reliable tests that can replace the liver biopsy for these purposes. Thus, identifying and validating potential novel noninvasive biomarkers is a central area of research. Moreover, longitudinal studies measuring these panels serially against clinical outcomes will determine if they can be used to measure disease progression and regression. Numerous other biomarkers of inflammation, oxidative stress, apoptosis, and fibrosis are under investigation. However, more studies are needed to validate the existing markers and techniques and develop other accurate noninvasive predictors of disease severity. The overall goal is to improve the quality of life and reduce long-term liver morbidity and mortality, as well as metabolic and cardiovascular complications. Liver ultrasonography is the most commonly used imaging modality, largely because it is relatively inexpensive, widely available, and is user-friendly. Moreover, liver ultrasonography can provide a good estimate of the degree or extent of hepatic steatosis present based on a series of ultrasound characteristics including hepatorenal echo contrast, liver echogenicity, visualization of intrahepatic vessels, and visualization of liver parenchyma and the diaphragm. Furthermore, ultrasound cannot rule out the presence of steatohepatitis or fibrosis. Both computed tomography and magnetic resonance imaging studies, especially the new technique of magnetic resonance spectroscopy, are more sensitive techniques for the quantification of steatosis. However, they have been used primarily in the research setting and their clinical utility is limited by their cost and the need for sedation, especially in children. Based on studies in adults, greater than 5% weight loss has been associated with significant improvement in liver histology. Consumption of carbohydrates should be limited (especially a high fructose, high glucose diet) and low-glycemic-index foods prioritized. Saturated fats are limited in favor of monounsaturated fatty acids as well as polyunsaturated fatty acids (especially omega3). However, more realistically, the subjects should be encouraged to incorporate moderate activity into everyday life. Multidisciplinary management, including a consultation with a registered dietician to assess quality of diet and measurement of caloric intake is important. For compliance purposes, it is beneficial to encourage participation of other family members in dietary and lifestyle changes. Several drugs have been studied in adults, including sibutramine, a selective serotonin reuptake inhibitor, and orlistat, producing fat malabsorption, both of which have been shown to improve liver enzyme levels and sonographic signs of fatty liver. Pediatric studies performed in obese adolescents (>12 years old) showed interesting weight loss effects. Hepatoprotective, Antioxidant Therapy Several therapeutic agents thought to offer hepatocyte protection have been evaluated. A randomized controlled trial of vitamin E in adults showed improvement in transaminases and fibrosis. Reports have demonstrated improvement in transaminase levels with different classes of drugs, but there is a lack of histologic follow-up in most of these studies. Enteric-coated cysteamine and omega-3 polyunsaturated fatty acid have shown promising effects in small studies in children, and larger trials are currently underway. Its incidence is predicted to continue to rise with the increase in the incidence of pediatric overweight and obesity. Lifestyle modifications, particularly weight loss, have been shown to be beneficial. Novel therapeutic strategies for those children with more advanced disease are being developed, including insulin-sensitizing agents, antioxidant agents, and hepatoprotective medications, but none are ready for prime time use in clinical practice. The natural history of nonalcoholic fatty liver disease in children: a follow-up study for up to 20 years. A 12-year-old Hispanic overweight boy is seen for evaluation of elevated liver enzymes on two occasions over the last 3 months. Moreover, it is helpful in ruling out alternate causes of hepatic steatosis, in particular chronic hepatitis C infection, Wilson disease, 905. A central limitation for the use of liver biopsy is its invasiveness and the potential association with significant complications such as bleeding and pain. Chronic portal inflammation has been linked to more severe fibrosis; however, it remains to be determined whether patients with the pediatric pattern differ in natural history, etiopathogenesis, prognosis, or response to treatment compared to patients with adult type or those with overlapping features. Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Changes in insulin resistance and cardiovascular risk during adolescence: establishment of differential risk in males and females. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction. Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease. Severity of liver injury and atherogenic lipid profile in children with nonalcoholic fatty liver disease. Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric nonalcoholic steatohepatitis. Discoveries in the field of molecular biology, microbiology, metabolism, and immunology have greatly expanded the viral "hepatitis alphabet" and our understanding of many of these infectious and inflammatory diseases. New questions have also been raised, and the body of information has become more complex. Often the history and clinical examination will provide important clues and guidelines in the choice of appropriate tests. Imaging studies such as ultrasonography or computed topography are valuable tools in the evaluation of patients with liver dysfunction. It is not required in all patients, especially for those with acute hepatitis in whom the etiologic diagnosis is known and who are expected to have a good prognosis. However, in cases when the etiology and/or the outcome are uncertain, examination of liver tissue may be critical in the determination of diagnosis and prognosis. The evaluation may be divided into the assessment of the clinical presentation, serologic testing and imaging, and histopathologic examination. A list of the most common differential diagnoses of hepatitis in childhood is provided in Box 75-1. Some children present with the typical signs and symptoms of hepatic damage, such as jaundice, abdominal pain, and malaise. A detailed history in a child with hepatitis should include an effort to determine the possible etiologic agent, such as exposure to hepatotoxic drugs, or mode of transmission, such as intravenous drug use or a family history of inherited or acquired liver disease. A complete physical examination should look for scleral, mucosal, or cutaneous icterus; and hepatosplenomegaly, ascites, edema, clubbing, petechiae, ecchymosis, spider angiomas, and mental state changes. Nonhepatic causes of aminotransferase elevation, such as congestive heart failure or myopathy, should be considered. The reported incidence of hepatitis A in the United States has been steadily declining, with only 1398 symptomatic cases reported in 2011. In these countries, 92% to 100% of 18-year-olds have serologic evidence of past infection. Because the disease is more severe in older patients, it poses a greater health problem in developed countries. Daycare centers are likely settings for transmission, especially if they have a large proportion of young children with orocentric behaviors or those not yet toilet trained. Under these conditions, the disease usually comes to medical attention from an infected adult staff member or an infected older household contact rather than the asymptomatic daycare vector. It is during this period and while the patient is asymptomatic, that viral transmission is most likely. Serum aminotransferase elevations may persist for several months and rarely for as long as a year. Examination may be remarkable for jaundice, evidence of dehydration, and a mildly enlarged, tender liver. These values are often 20 to 100 times the upper limit of normal, and decrease rapidly within the first 2 to 3 weeks, although minor elevations may persist for months. Most complications are rare, and the fatality rate from fulminant hepatitis in children younger than 14 years of age is 0. The most frequent example of the latter occurs in the daycare setting or in household contacts. Two preparations are currently available, both made from formalin-inactivated virus grown in culture. The recommended schedule is two injections 6 to 12 months apart, and 99% of children develop protective levels of antibody. The most frequent side effects reported in children are pain and tenderness at the injection site. Vaccines should replace serum immunoglobulin for use in preexposure cases and may be active in interrupting epidemics. It may be reasonable in such situations to use both active and passive immunization. The incidence of hepatitis A has been falling since 1998, commensurate with the increasing use of widespread vaccination. It is the only member of this family capable of infecting humans and nonhuman primates. The presence of a viral shell has been associated with the development of chronicity and carcinoma. Genotype C is associated with more severe liver disease than genotype B,38 and genotype D with more severe liver disease than genotype A. The factors that determine a specific response, whether it is viral eradication, chronic persistent infection, or fulminant hepatitis, are incompletely defined. This is supported by the observation that these children most often demonstrate little, if any, hepatic inflammatory injury. A 1985 study by McMahon and associates58 followed 1280 seronegative Eskimos in an endemic area of Alaska for 5 years. The results show that age of infection is inversely related to likelihood of asymptomatic infection and to the development of chronicity. In areas where prevalence rates are high, the disease is acquired perinatally or at a very young age. Chronically infected individuals represent a persistent reservoir for infection and contribute significantly over their life spans to the maintenance of high endemicity. In areas of low endemicity, the infection is acquired in adulthood and is less likely to become chronic and generate high prevalence rates. Small pockets of high prevalence exist and may be associated with ethnic minorities. In a mobile society, it is important to recognize these geographic differences because it is not unusual to care for patients emigrating from areas of high endemicity. The traditional route of transmission is parenteral, through contaminated transfused blood products or needles for intravenous drug use. Transmission may also occur percutaneously or transmucosally from exposure to blood or other contaminated body fluids. The route of acquisition within the pediatric population can be divided into three relevant age groups: perinatal, infancy-childhood, and adolescent­young adult. Infants and children who do not become infected perinatally remain at high risk of infection during the first 5 years of life. However, among the 48% with a reported exposure, 55% were from sexual contact and 15% from intravenous drug use. The maleto-female ratio in adolescents is equal, but in adults, there is a slight male predominance. The incubation period ranges from 28 to 180 days (mean 80 days), after which the patient may develop a prodrome consisting of fever, anorexia, fatigue, malaise, and nausea.

Additional information:

• Danazol

References

• Chevalier X, Eymard F, Richette P. Biologic agents in osteoarthritis: hopes and disappointments. Nat Rev Rheumatol 2013; 9:400-10.
• Mowry JB, Spyker DA, Brooks DE, et al: 2014 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 32nd annual report. Clin Toxicol (Phila) 53(10):962-1147, 2015.
• Chandran GJ, Chung B, Lalonde J, Lalonde DH. The hyperthermic effect of a distal volar forearm nerve block: a possible treatment of acute digital frostbite injuries? Plast Reconstr Surg 126:946, 2010.
• Bristow RE, Montz FJ, Lagasse LD, et al. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Gynecol Oncol. 1999;72:278-287.
• Barnes L, Kapadia SB. 1994.
• Voss MH, Hakimi AA, Pham CG, et al. Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy. Clin Cancer Res 2014;20(7):1955-1964.
• Holmgren G, Blomquist HK. Nonketotic hyperglycinemia in 2 sibs with mild psycho-neurological symptoms. Neuropaediatrie 1977;8:67.
• Lederle FA, Simel DL: The rational clinical examination. Does this patient have abdominal aortic aneurysm? JAMA 281:77-82, 1999.